Why Genetic Diversity Research Requires Advanced SNP Genotyping

Understanding genetic diversity across global populations is fundamental to advancing population genomics, precision medicine, pharmacogenomics, and genome-wide association studies (GWAS). However, many conventional genotyping platforms were developed using reference datasets that inadequately represent diverse ancestries. This limited representation can reduce the accuracy of genetic association studies, hinder the identification of population-specific variants, and restrict discoveries with clinical, agricultural, and biomedical significance.

The Infinium Global Diversity Array (GDA) was specifically designed to overcome these challenges. Featuring over 1.8 million expertly selected genetic markers, the array delivers comprehensive coverage of genetic variation across diverse populations, enabling more accurate variant detection and enhanced genomic resolution. For research institutions, contract research organizations (CROs), biotechnology companies, and pharmaceutical organizations, this translates into highly reliable genotyping data, improved statistical confidence, and globally representative datasets that support meaningful scientific discoveries.

Powered by Illumina's proven Infinium® assay technology, the Global Diversity Array combines exceptional SNP coverage, high reproducibility, and scalable throughput to support projects ranging from targeted cohort studies to large international genomic initiatives. It empowers researchers to perform inclusive, population-scale analyses while ensuring consistent, high-quality data across diverse study populations.

What Is the Infinium Global Diversity Array (GDA)?

The Infinium Global Diversity Array (GDA) is a high-density SNP genotyping platform developed by Illumina to enable accurate, reproducible, and large-scale genetic analysis across globally diverse populations. Built on Illumina's trusted Infinium® chemistry, the platform delivers robust genotyping performance for a wide range of genomic research applications.

N2Jenomics Lab Pvt. Ltd. offers two flexible GDA formats to accommodate varying project sizes and throughput requirements:

• • Infinium Global Diversity Array-8 (GDA-8): A medium-throughput solution ideally suited for academic research, pilot studies, and targeted population cohorts.

• • Infinium Global Diversity Array-24 (GDA-24): A high-throughput platform designed for large-scale population studies, multicenter research projects, pharmaceutical research, and CRO applications.

Both platforms feature more than 1.8 million carefully curated single nucleotide polymorphism (SNP) markers, strategically selected to maximize genetic diversity representation across multiple ancestries. This extensive genomic coverage makes the arrays ideal for genome-wide association studies (GWAS), population genetics, ancestry analysis, pharmacogenomics, disease susceptibility research, biomarker discovery, and precision medicine.

By combining comprehensive genomic coverage, scalable throughput, and exceptional data quality, the Infinium Global Diversity Array enables researchers to choose the platform that best aligns with their study objectives, sample size, and budget, while maintaining outstanding reproducibility and cross-study data consistency.

Choosing Between Infinium GDA-8 and GDA-24

The Infinium Global Diversity Array offers two throughput formats to fit different project needs. Both platforms deliver identical SNP marker content and quality, but differ in scale and efficiency.

Key Advantages of the Infinium Global Diversity Array (GDA) Service

The Infinium Global Diversity Array (GDA) service offers a powerful combination of comprehensive genomic coverage, high accuracy, and scalable throughput, making it an ideal solution for population genetics, genome-wide association studies (GWAS), pharmacogenomics, and large-scale genomic research.

• Comprehensive Genome-Wide Coverage

Featuring more than 1.8 million carefully curated SNP markers derived from diverse global reference populations, the Infinium GDA provides extensive genome-wide coverage. Its inclusive design enhances variant detection across multiple ancestries, enabling more representative and unbiased genetic analyses.

• Scalable Throughput for Every Project

The Infinium GDA is available in two flexible formats to accommodate projects of varying sizes:

• - Infinium Global Diversity Array-8 (GDA-8): Ideal for medium-throughput studies, pilot projects, and academic research.
• - Infinium Global Diversity Array-24 (GDA-24): Optimized for high-throughput population studies, large research cohorts, CROs, and pharmaceutical research.

Both platforms deliver consistent performance while offering a cost-effective solution for studies ranging from hundreds to thousands of samples.

• Exceptional Accuracy and Reproducibility

Powered by Illumina's industry-leading Infinium® assay technology, the GDA platform delivers highly accurate, reproducible, and reliable SNP genotyping results. Its validated chemistry and standardized workflows ensure consistent data quality across experiments, laboratories, and research sites.

• Reliable Cross-Study Data Comparability

As one of the most widely adopted genotyping platforms in academic, clinical, CRO, and pharmaceutical research, the Infinium GDA enables seamless comparison of datasets across independent studies. This standardized approach facilitates collaborative research, meta-analyses, longitudinal studies, and global genomics initiatives.

• Optimized for Population-Scale Genomics

By combining comprehensive genomic coverage, flexible throughput options, industry-leading accuracy, and standardized data generation, the Infinium Global Diversity Array overcomes the limitations of conventional or population-specific genotyping panels. It empowers researchers with high-quality, reproducible genomic data, enabling confident discoveries in population genomics, precision medicine, biomarker discovery, pharmacogenomics, and genetic epidemiology.

Workflow

Applications Across Research and Industry

• The Infinium Global Diversity Array (GDA) is a versatile high-density SNP genotyping platform designed to support a broad spectrum of research and industrial applications. Its comprehensive genomic coverage, exceptional accuracy, and scalable throughput make it an ideal solution for studies involving diverse populations and large sample cohorts.

• Human genetics and population genomics

The Infinium GDA is extensively used in genome-wide association studies (GWAS), population genetics, ancestry analysis, genetic epidemiology, and precision medicine research. With SNP markers carefully selected to represent diverse global populations, the platform enables more comprehensive, inclusive, and accurate investigations of genetic diversity, disease susceptibility, and population structure.

• Pharmaceutical R&D and CRO projects

Pharmaceutical companies and CROs leverage the Infinium GDA for pharmacogenomics, biomarker discovery, companion diagnostics, and translational research. Its high-density and reproducible SNP genotyping supports the identification of genetic variants associated with drug response, therapeutic efficacy, and adverse drug reactions, accelerating precision medicine and drug development programs.

• Agricultural genomics

The platform also supports plant, livestock, and agricultural genomics by enabling high-resolution genetic analysis for breeding programs, trait mapping, genomic selection, and diversity studies. Researchers can efficiently identify valuable genetic markers that contribute to improved crop productivity, disease resistance, livestock performance, and sustainable agricultural practices.

• Large-scale cohort studies

The Infinium Global Diversity Array-24 (GDA-24) is specifically designed for high-throughput genotyping of large research cohorts, making it well-suited for national biobanks, multicenter clinical studies, international genomics consortia, and population-scale research initiatives. Its standardized workflow ensures consistent, high-quality data generation across thousands of samples, facilitating robust cross-study comparisons and collaborative research.

• Advancing Genomic Discovery Across Multiple Disciplines

By combining comprehensive genome-wide SNP coverage, scalable throughput, and industry-leading data quality, the Infinium Global Diversity Array empowers researchers across academia, healthcare, biotechnology, pharmaceutical development, and agriculture. It provides reliable, reproducible, and globally representative genotyping data that supports groundbreaking discoveries in human health, precision medicine, crop improvement, livestock genetics, and population genomics

Data Quality and Reliability Built on Industry-Leading Standards

Generating accurate, reproducible, and high-quality genotyping data is critical for successful population-scale genetic research. The Infinium Global Diversity Array (GDA) is powered by Illumina's proven Infinium® technology, a globally recognized platform trusted by leading academic institutions, clinical laboratories, CROs, and pharmaceutical organizations for high-performance SNP genotyping.

• Validated Infinium® Technology

Built on Illumina's extensively validated Infinium assay chemistry, the Global Diversity Array delivers highly accurate and reproducible SNP genotyping through optimized hybridization, extension, and detection workflows. Its standardized methodology ensures consistent performance across multiple projects, laboratories, and experimental batches.

• Trusted in Global Genomics Research

The Infinium Global Diversity Array has been widely adopted in large-scale international genomics initiatives, including genome-wide association studies (GWAS), multi-ethnic population studies, pharmacogenomics programs, and precision medicine research. Its broad acceptance by global research consortia reflects its proven reliability, accuracy, and cross-study compatibility.

• Comprehensive Quality Control (QC)

At N2Jenomics Lab Pvt. Ltd., every genotyping project follows a rigorous quality assurance workflow to ensure exceptional data integrity. Our quality control process includes DNA quantity and quality assessment, sample validation, array processing, genotype calling, data filtering, and comprehensive performance evaluation, delivering reliable datasets ready for downstream analysis.

• Exceptional Reproducibility Across Studies

Standardized laboratory protocols, automated workflows, and robust data processing pipelines ensure excellent reproducibility across different laboratories, study sites, and time points. This consistency is essential for multicenter collaborations, longitudinal studies, meta-analyses, and population-scale genomics projects where data comparability is paramount.

• Confidence in Every Genotyping Result

By combining Illumina's industry-leading Infinium® platform with the scientific expertise of N2Jenomics Lab Pvt. Ltd., researchers receive high-quality, reproducible, and dependable SNP genotyping data. Our end-to-end workflow—from sample quality assessment to advanced bioinformatics analysis—provides the confidence needed to support robust genetic discoveries, precision medicine initiatives, and large-scale population genomics research.

Why Choose N2Jenomics Lab Pvt. Ltd. for Infinium Global Diversity Array (GDA) Services?

Selecting the right genomics partner is essential for achieving accurate, reproducible, and meaningful SNP genotyping results. At N2Jenomics Lab Pvt. Ltd., we combine industry-leading Illumina® technology with extensive expertise in population genomics, SNP array analysis, and bioinformatics to deliver reliable, high-quality data for research projects of every scale.

• Comprehensive End-to-End Genotyping Solutions

We provide complete project management from start to finish, including sample quality assessment, DNA extraction, array processing, genotyping, data analysis, and advanced bioinformatics. Our integrated workflow minimizes technical variability, streamlines project execution, and ensures timely delivery of high-quality results.

• Experienced Scientific and Technical Expertise

Our multidisciplinary team of molecular biologists, genomic scientists, and bioinformaticians has extensive hands-on experience with Illumina Infinium® genotyping platforms. We employ validated laboratory protocols and optimized analytical workflows to ensure exceptional accuracy, reproducibility, and data integrity throughout every project.

• Advanced Bioinformatics and Data Analysis

Beyond laboratory processing, we offer comprehensive bioinformatics support tailored to your research objectives. Our analysis services include SNP calling, genotype quality control, population structure analysis, ancestry analysis, genome-wide association study (GWAS)-ready datasets, variant annotation, statistical analysis, and customized reporting, enabling researchers to derive meaningful biological insights from their data.

• Scalable Solutions for Every Research Program

Whether you're conducting a small pilot study, an academic research project, a multicenter collaboration, or a large-scale pharmaceutical or CRO-based genomics program, our flexible infrastructure and scalable workflows are designed to efficiently support projects ranging from dozens to thousands of samples.

• Reliable Quality, Trusted Results

At N2Jenomics Lab Pvt. Ltd., we are committed to delivering accurate, reproducible, and publication-ready genotyping data backed by rigorous quality control and internationally recognized best practices. By partnering with us, researchers gain access to advanced genomics technologies, expert scientific support, and end-to-end solutions that accelerate discoveries in population genomics, pharmacogenomics, precision medicine, biomarker discovery, and genetic research.

Q1: What is the Infinium Global Diversity Array (GDA) used for?

The Infinium Global Diversity Array (GDA) is a high-density SNP genotyping platform designed for large-scale genetic studies. It is widely used in population genomics, genome-wide association studies (GWAS), ancestry analysis, pharmacogenomics, biomarker discovery, precision medicine, and agricultural genomics  providing comprehensive genomic insights across diverse populations.

Q2: What is the difference between Infinium GDA-8 and Infinium GDA-24?

Both Infinium GDA-8 and Infinium GDA-24 contain the same comprehensive panel of more than 1.8 million SNP markers, ensuring identical genomic coverage and data quality. The primary difference is throughput:

• • Infinium GDA-8: Designed for medium-throughput projects, pilot studies, and academic research.

• • Infinium GDA-24: Optimized for high-throughput genotyping of large research cohorts, making it ideal for CROs, pharmaceutical organizations, and population-scale genomic studies while reducing the per-sample cost.

Q3: How accurate and reliable are the results generated by the Infinium Global Diversity Array?

The Infinium Global Diversity Array is built on Illumina's proven Infinium® technology, which is extensively validated and widely adopted by leading research institutions worldwide. At N2Jenomics Lab Pvt. Ltd., every project undergoes rigorous quality control, including DNA quality assessment, standardized laboratory workflows, genotype calling, and comprehensive data validation to ensure highly accurate, reproducible, and reliable results.

Q4: What deliverables will I receive after completing my project?

Our standard deliverables include comprehensive datasets and analysis outputs, such as:

• • Raw genotype data
• • Quality control (QC) reports
• • Processed SNP genotype datasets
• • Genotype calling and summary reports
• • GWAS-ready datasets
• • Population structure and ancestry analysis (optional)
• • Customized bioinformatics analysis and project reports (upon request)

These deliverables are designed to support downstream analyses, publication-ready research, and further biological interpretation.

Q5: Why should I choose N2Jenomics Lab Pvt. Ltd. for Infinium Global Diversity Array services?

N2Jenomics Lab Pvt. Ltd. provides a complete end-to-end Infinium Global Diversity Array service, combining expert sample processing, Illumina® genotyping, advanced bioinformatics, and dedicated scientific support under one roof. Our experienced team delivers scalable solutions for academic institutions, research laboratories, CROs, biotechnology companies, and pharmaceutical organizations, ensuring high-quality, reproducible results with fast turnaround times and comprehensive analytical support for projects of any size.